Amid disputes over Sputnik V’s effectiveness, the Russian government continues to defend itself as they wait for the results confirmed by current pronowatts, which confirm that it has no adverse effects on people over the age of 60. On this occasion, from the Nikolai Gamaleya Center for Epidemiology and Microbiology they spoke out about this situation and made it clear that the records obtained are very optimistic. «Soon the results of studies in the elderly will be released, there are no side effects,» they said.
Sputnik V, the vaccine that arrived in Argentina on Thursday, December 24. Photo: NA
The communications officer was the centre director, Alexandr Guintsburg, in statements that were replicated by the local news agency Sputnik. In addition, from the same institute they confirmed that no samples were received from the new strain of coronavirus detected in the UK, although they claim that inoculation protects against this variant. The Sputnik V vaccine consists of two components: the first is based on human adenovirus type 26, and the second, in recombinant human adenovirus type 5, is administered twice, in an interval of 21 days. At the moment, only recommended for people between 18 and 60 years old. The latest data from the third phase of clinical trials on the vaccine show an efficacy of more than 90% and the same began to be applied in the country, while Argentina received 300,000 doses this day Thursday, December 24 and in the course of next week will be applied in different provinces and cities of the country.